Browsing Year-2022 by Subject "SARS-CoV-2"

Now showing items 1-3 of 3

Fiction and facts about BCG imparting trained immunity against COVID-19

Kaur, G.; Singh, S.; Nanda, S.; Zafar, M.A.; Malik, J.A.; Arshi, M.U.; Lamba, T.; Agrewala, J.N. (2022-07-17)

The Bacille Calmette-Guérin or BCG vaccine, the only vaccine available against Mycobacterium tuberculosis can induce a marked Th1 polarization of T-cells, characterized by the antigenspecific secretion of IFN-γ and enhanced ...
The impact of COVID-19 on Comorbidities: a review of recent updates for combating it

Ahmad Malik, J.; Ahmed, S.; Shinde, M.; Almermesh, M. J. S.; Alghamdi, S.; Hussain, A.; Anwar, S. (2022-04-24)

Coronavirus disease is caused by the SARS-CoV-2 virus. The virus first appeared in Wuhan (China) in December 2019 and has spread globally. Till now, it affected 269 million people with 5.3 million deaths in 224 countries ...
SARS-CoV-2 vaccines: Clinical endpoints and psychological perspectives: A literature review

Malik, J.A.; Aroosa, M.; Ahmed, S.; Shinde, M.; Alghamdi, S.; Almansour, K.; Hagbani, T.A.; Alanazi, M.S.; Anwar, S. (2022-05-29)

Background: About 270 million cases have been confirmed, and 5.3 million fatalities Worldwide due to SARS-CoV-2. Several vaccine candidates have entered phase 3 of the clinical trial and are being investigated to provide ...

Now showing items 1-3 of 3

Search DSpace